Interference-Free Surface-Enhanced Raman Scattering Tags for Single-Cell Molecular Imaging with a High Signal-to-Background Ratio

Small ◽  
2017 ◽  
Vol 13 (15) ◽  
pp. 1603340 ◽  
Author(s):  
Sisi Ma ◽  
Qiang Li ◽  
Yongmei Yin ◽  
Jie Yang ◽  
Dingbin Liu
Keyword(s):  
Free Surface ◽  
Molecular Imaging ◽  
Raman Scattering ◽  
Single Cell ◽  
Surface Enhanced Raman Scattering ◽  
High Signal ◽  
Background Ratio ◽  
Surface Enhanced ◽  
Surface Enhanced Raman ◽  
Enhanced Raman Scattering

scholarly journals Surface-Enhanced Raman Scattering Based Microfluidics for Single-Cell Analysis

2018 ◽  
Vol 90 (20) ◽  
pp. 12004-12010 ◽  
Author(s):  
Marjorie R. Willner ◽  
Kay S. McMillan ◽  
Duncan Graham ◽  
Peter J. Vikesland ◽  
Michele Zagnoni
Keyword(s):  
Raman Scattering ◽  
Single Cell ◽  
Single Cell Analysis ◽  
Surface Enhanced Raman Scattering ◽  
Cell Analysis ◽  
Surface Enhanced ◽  
Surface Enhanced Raman ◽  
Enhanced Raman Scattering

Label-Free Surface-Enhanced Raman Scattering Imaging to Monitor the Metabolism of Antitumor Drug 6-Mercaptopurine in Living Cells

2014 ◽  
Vol 86 (23) ◽  
pp. 11503-11507 ◽  
Author(s):  
Guangmei Han ◽  
Renyong Liu ◽  
Ming-Yong Han ◽  
Changlong Jiang ◽  
Jianping Wang ◽  
...  
Keyword(s):  
Free Surface ◽  
Raman Scattering ◽  
Surface Enhanced Raman Scattering ◽  
Living Cells ◽  
Antitumor Drug ◽  
Label Free ◽  
Surface Enhanced ◽  
Surface Enhanced Raman ◽  
Enhanced Raman Scattering

scholarly journals Controlled release of targeted chemotherapeutic drug dabrafenib for melanoma cancers monitored using surface-enhanced Raman scattering (SERS) spectroscopy

2018 ◽  
Vol 7 (1) ◽  
pp. 18-27 ◽  
Author(s):  
Logan Running ◽  
Ricardo Espinal ◽  
Maria Hepel
Keyword(s):  
Controlled Release ◽  
Drug Release ◽  
Raman Scattering ◽  
Surface Enhanced Raman Scattering ◽  
Drug Binding ◽  
Amide Bond ◽  
High Signal ◽  
Surface Enhanced ◽  
Surface Enhanced Raman ◽  
Enhanced Raman Scattering

The advanced skin cancer melanoma, which is primarily caused by the mutation of BRAF gene, has a high mortality rate and requires high doses of chemotherapeutic drugs. To mitigate the drug toxicity to healthy cells and other side effects, the development of alternative modes of treatment has been extensively sought after. Herein, we describe a new targeted drug delivery system with controlled release, based on nanoparticle nanocarriers functionalized with folate and transferrin ligands for recognition of the respective receptors overexpressed in cancer cell membrane. We have investigated the immobilization of a new drug dabrafenib onto the nanocarriers and its controlled release, aided with surface-enhanced Raman scattering (SERS) spectroscopy which affords ultra-sensitive in situ measurement ability owing to the high signal amplification, associated with strong plasmonic fields of the nanocarrier gold nanoparticle (AuNP) cores. The nanocarriers were equipped with Raman reporters: mercaptobenzoic acid (MBA) and para-aminothiophenol (PATP) forming a mixed thiolate monolayer shell on AuNPs. The dabrafenib was covalently attached to MBA via an amide bond which is pH sensitive and enables the drug release at lower pH encountered in cancer cells. This arrangement in the drug binding to the nanocarrier protects the dabrafenib amine group against deactivation until the drug release in the target tumor cells.

Sign in / Sign up

Export Citation Format

Share Document